NIH collaborates with diagnostics manufacturers on obtaining authorization of multiplex tests: To date, nine medical device developers participating in the RADx® Tech Independent Test Assessment Program have received emergency use authorization for at-home and point-of care test products that simultaneously detect COVID-19 and flu A/B.
No hay comentarios:
Publicar un comentario